Nobel Biocare: Slight improvement but situation remains more than challenging

SELL, Fair Value CHF8.9 (-10%)

News published on February Tuesday 19, 2013
Share on

Revenue for 2012 was EUR580.5m (consensus : EUR578.5m) driven once again by the Americas (39% of sales, +1.8% CER). EMEA remained under pressure (41% of sales, -3.6% CER) while Asia/Pacific (21% of sales, -8.6% CER) suffered from a media campaign in Japan where the market was down 15% and represents 60% of regional revenue.

Full report available to subscribers
Please contact

The Essentials

Everything you need to know about investment banking dedicated to growth
Stay Informed
Get our news
Join our Team
Bryan, Garnier & Co is always looking for talent in all our divisions, at all levels
Explore our opportunities